It refers to retatrutide, a tripleagonist weightloss medication that activates GLP1, GIP, and glucagon receptors. Early clinical trials show unprecedented weightloss results, often greater than currently approved GLP1 and dualagonist drugs, along with improvements in liver fat and metabolic markers. As research advances and more data become available, medically supervised programs will continue to evaluate where TRIPLEagonist medications fit among GLP1 drugs, dualagonists, peptides, and other tools for sustainable metabolic health
Nausea and Vomiting: Common side effects include severe nausea, vomiting, and facial flushing
& Shimada, S
Some clients come in as needed, while others receive drips on a regular schedule
As an AHA, Lactic Acid too exfoliates skin by dissolving the glue that holds skin cells together to reveal the brighter and smoother skin underneath